BRITTNEY CAMPBELL: Open Payments
NPI 1427374396 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$725 in 30 payments from 10 companies in 2025. Trend: 2023 $667 · 2024 $804 · 2025 $725
Food & beverage: $725
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $175 |
| Merck Sharp & Dohme LLC | 5 | $113 |
| SK Life Science, Inc. | 3 | $100 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $98 |
| Boston Scientific Corporation | 1 | $55 |
| Alexion Pharmaceuticals, Inc. | 2 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
| Smith+Nephew, Inc. | 2 | $39 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: ELIQUIS, ZERBAXA, XIFAXAN, General - Therapies, JARDIANCE, COLLAGENASE SANTYL, ULTOMIRIS, LifeVest.
Industry payments across NC — which companies pay providers there.
